If NAMPT is to be a viable target for drugs to prevent CIPN, it is critical to determine whether stimulation of NAMPT with P7C3-A20 enhances tumor growth or whether it interferes with the anticancer activity of PTX. The gene discussed is NAMPT; the disease is neoplasm.